● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
● Its low valuation, with P/E ratio at 8.06 and 9.37 for the ongoing fiscal year and 2023 respectively, makes the stock pretty attractive with regard to earnings multiples.
● The company shows low valuation levels, with an enterprise value at 0.81 times its sales.
● The company's share price in relation to its net book value makes it look relatively cheap.
● The company has a low valuation given the cash flows generated by its activity.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
● Over the past four months, analysts' average price target has been revised upwards significantly.
● Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
● The company sustains low margins.
● The group shows a rather high level of debt in proportion to its EBITDA.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.